Skip to content

Saphenous Nerve Block for Partial Meniscectomy

Surgeon Performed Saphenous Nerve Block at the Medial Femoral Condyle for Arthroscopic Partial Meniscectomy and Meniscus Repair: A Randomized Control Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04717609
Enrollment
160
Registered
2021-01-22
Start date
2021-01-25
Completion date
2022-01-25
Last updated
2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Joint, Pain, Procedural, Meniscectomy

Brief summary

Partial meniscectomy and meniscus repair are two of the most common orthopedic surgery procedures. As these procedures are being increasingly performed in ambulatory surgical centers, there has been a shift towards providing improved analgesia to ensure timely discharge, as well as preventing unwanted pain and side effects. As such, it has become common practice to use an intra-articular injection of local anesthetic to achieve post-operative pain control. However, these effects are short lived, requiring a multimodal approach to analgesia. To date, no optimal pain control strategy has been described for arthroscopic partial meniscectomy or meniscus repair. The purpose of this study is to examine the outcomes of subcutaneous saphenous nerve block with 0.5% ropivacaine at the medial femoral epicondyle/adductor hiatus plus portal 0.5% ropivacaine injection vs portal 0.5% ropivacaine injection alone for patients undergoing arthroscopic partial meniscectomy or meniscus repair.

Interventions

Preoperative Saphenous Nerve Block for partial Meniscectomy

DRUGRopivacaine injection

preoperatively the participant will receive an injection ar the surgical site of 5 milliliters (mL) of 0.5% ropivacaine

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 * Scheduled for arthroscopic meniscectomy or meniscus repair

Exclusion criteria

* Multiple-ligament injury * Primary ACL reconstruction or ACL revision reconstruction * Articular cartilage restoration surgery * Evidence of microfracture * History of allergy to local anesthetics * Pre-existing saphenous neuropathy * Unable to be prescribed opioids due to allergy or other reason

Design outcomes

Primary

MeasureTime frameDescription
Reduced Pain Levels10 daysThis will be measured by Participant Opioid Use will be collected everyday for 10 days after surgery
Quality of Recovery20 minutesAfter surgery while in the recovery room a 40 question survey will be administered regarding your comfort level, emotional state and pain

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026